CD73 inhibitors and uses thereof
US11591355B2 · kind B2 · utility
1Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2021 |
| Grant date | Feb 28, 2023 |
| Priority date | — |
| Expiry date | Sep 17, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/23
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure provides compounds of Formula (II)wherein R1, R2, R3, R4, R5, W1, W2, W3, X, Y, and A are as described herein. The disclosed compounds modulate CD73 activity. The present disclosure also provides, pharmaceutical compositions containing these compounds, and methods of using these compounds for treating diseases associated with CD73 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.